Dr. Rakhee Vaidya
Claim this profileWake Forest University Health Sciences
Studies Lymphoma
Studies B-Cell Lymphoma
9 reported clinical trials
15 drugs studied
Area of expertise
1Lymphoma
CD30 positive
Stage IV
CCND1 positive
2B-Cell Lymphoma
CCND1 positive
t(11;14) positive
CD19 positive
Affiliated Hospitals
Clinical Trials Rakhee Vaidya is currently running
CD30 CAR T-Cell Therapy
for Lymphoma
This is a research study to determine the safety and tolerability of ATLCAR.CD30 for treating relapsed/refractory Peripheral T Cell Lymphoma. Blood samples will be collected from study participants and the immune T cells will be separated. T cells will be genetically modified in a laboratory at UNC-Chapel Hill to enable them to produce CD30 antibody. The modified T cells, called ATLCAR.CD30, will be able to target and attach to lymphoma cancer cells that carry the CD30 antigen. Once they are attached, the hope is that the T cells will attack and destroy the lymphoma cancer cells. To prepare the body for the ATLCAR.CD30 cells, participants will complete lymphodepletion with two chemotherapy agents. Lymphodepletion will happen over three days prior to ATLCAR.CD30 infusion. If participants respond to this treatment, and there are sufficient unused ATLCAR.CD 30 cells, they may be eligible to receive a second infusion. The second infusion will be given after a second lymphodepletion chemotherapy. Most of the clinic visits in this research will last between 1-8 hours. There are risks associated in participating in this research study. Risks of treatment include infection, fever, nausea, vomiting, neurotoxicity, and cytokine release syndrome which can include low blood pressure or difficulty breathing. Other risks are associated with study procedures, such as biopsies, imaging, infusion, and breach of confidentiality.
Recruiting1 award Phase 210 criteria
Post-CAR T-cell Therapy Drug Combo
for Non-Hodgkin's Lymphoma
This trial is testing two treatments, mosunetuzumab and polatuzumab vedotin, for patients with certain types of lymphoma that have come back or don't respond to other treatments. These treatments aim to stop cancer cells from growing or kill them directly. The goal is to see if these treatments can better control or shrink the cancer compared to not using them.
Recruiting1 award Phase 2
More about Rakhee Vaidya
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Rakhee Vaidya has experience with
- Autologous Hematopoietic Stem Cell Transplantation
- ASTX660
- Rituximab
- Ibrutinib
- Autologous Bone Marrow Transplantation
- Prednisone
Breakdown of trials Rakhee Vaidya has run
Lymphoma
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rakhee Vaidya specialize in?
Rakhee Vaidya focuses on Lymphoma and B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved CD30 positive patients, or patients who are Stage IV.
Is Rakhee Vaidya currently recruiting for clinical trials?
Yes, Rakhee Vaidya is currently recruiting for 3 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Rakhee Vaidya has studied deeply?
Yes, Rakhee Vaidya has studied treatments such as Autologous Hematopoietic Stem Cell Transplantation, ASTX660, Rituximab.
What is the best way to schedule an appointment with Rakhee Vaidya?
Apply for one of the trials that Rakhee Vaidya is conducting.
What is the office address of Rakhee Vaidya?
The office of Rakhee Vaidya is located at: Wake Forest University Health Sciences, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest University Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.